Trametinib
Who holds supplier records for Trametinib? 3 organisations hold a current record for Trametinib: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (2) and China (1).
Most records are filed under another form of this substance: Trametinib Dimethyl Sulfoxide (5 current sources). A DMF or CEP is listed under the form it names.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Trametinib: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/trametinib
Reading the evidence
- 3 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
2 of the 3 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (3)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Trametinib. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 40493 · latest filing Sept 2024
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 31589 · latest filing Mar 2017
- Zhejiang Ausun Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 43552 · latest filing Mar 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Trametinib is a kinase inhibitor used for the treatment of melanoma, specifically targeting MEK1 and MEK2. It is often used in combination with other medications to treat unresectable or metastatic melanoma with a mutation in the BRAF gene.
Chemical identity
- IUPAC name
- N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
- Canonical SMILES
- CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5
- InChIKey
- LIRYPHYGHXZJBZ-UHFFFAOYSA-N
- Synonyms
- Mekinist API, gsk-1120212, gsk1120212, jtp 74057, jtp-74057, tmt-212, tmt212
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Trametinib?
3 organisations hold an active US FDA Type II Drug Master File or a CEP for Trametinib: Alembic Pharmaceuticals Limited (India), MSN Laboratories Private Limited (India) and Zhejiang Ausun Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Trametinib Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 40493), MSN Laboratories Private Limited (DMF 31589) and Zhejiang Ausun Pharmaceutical Co., Ltd. (DMF 43552). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Trametinib supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Trametinib?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.